7,068 Danaher Corporation $DHR Shares Acquired by Sax Wealth Advisors LLC

Key Points

• Sax Wealth Advisors increased its Danaher stake by 197.2% in the third quarter, acquiring 7,068 additional shares and bringing its total holdings to 10,652 shares valued at approximately $2.36 million.
• Institutional ownership remains high at 79.05%, with several other investment firms also increasing or initiating positions in Danaher during the quarter.
• Danaher reported quarterly earnings of $1.94 per share, exceeding estimates, while analysts maintain a “Moderate Buy” consensus rating with an average price target of $235.41.

Sax Wealth Advisors LLC lifted its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 197.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 10,652 shares of the conglomerate's stock after acquiring an additional 7,068 shares during the period. Sax Wealth Advisors LLC's holdings in Danaher were worth $2,360,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. NorthCrest Asset Manangement LLC boosted its position in shares of Danaher by 568.9% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 22,744 shares of the conglomerate's stock valued at $5,039,000 after acquiring an additional 19,344 shares during the last quarter. Value Investment Professionals LLC purchased a new stake in shares of Danaher in the third quarter valued at about $627,000. Avior Wealth Management LLC increased its position in Danaher by 12.0% during the third quarter. Avior Wealth Management LLC now owns 10,648 shares of the conglomerate's stock worth $2,359,000 after purchasing an additional 1,137 shares during the last quarter. Woodstock Corp acquired a new stake in Danaher during the third quarter worth about $214,000. Finally, JGP Wealth Management LLC increased its position in Danaher by 12.2% during the third quarter. JGP Wealth Management LLC now owns 5,184 shares of the conglomerate's stock worth $1,149,000 after purchasing an additional 564 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

NYSE:DHR opened at $223.30 on Wednesday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $156.98 billion, a P/E ratio of 39.66, a P/E/G ratio of 2.78 and a beta of 0.76. The stock's fifty day moving average is $212.41 and its two-hundred day moving average is $195.13.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company's quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.77 EPS. Equities analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher's payout ratio is 28.42%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. UBS Group initiated coverage on shares of Danaher in a research note on Wednesday, September 9th. They set a "buy" rating and a $250.00 target price on the stock. Guggenheim increased their price target on shares of Danaher from $200.00 to $250.00 and gave the company a "buy" rating in a research note on Thursday, October 1st. Evercore reissued an "outperform" rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Morgan Stanley raised their price target on shares of Danaher from $220.00 to $240.00 and gave the stock an "overweight" rating in a report on Monday. Finally, The Goldman Sachs Group raised their price target on shares of Danaher from $210.00 to $250.00 and gave the stock a "buy" rating in a report on Monday, September 21st. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and a consensus target price of $235.41.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.